title: Acute coronary syndrome secondary to fluorouracil infusion.
authors.affiliation: State University of New York Upstate Medical University, Syracuse, NY, USA.
authors.forename: Jack I
authors.initials: JI
authors.lastname: Lu
authors.forename: Robert L
authors.initials: RL
authors.lastname: Carhart
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Graziano
authors.forename: Ajeet
authors.initials: A
authors.lastname: Gajra
mesh_terms: D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000556:secondary*; D002945:Cisplatin / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects*; D006258:Head and Neck Neoplasms / Q000473:pathology / Q000628:therapy; D006801:Humans; D007262:Infusions, Intravenous; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000964:Antimetabolites, Antineoplastic; D002945:Cisplatin; D005472:Fluorouracil